1. Home
  2. ARCT vs SPTN Comparison

ARCT vs SPTN Comparison

Compare ARCT & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • SPTN
  • Stock Information
  • Founded
  • ARCT 2013
  • SPTN 1917
  • Country
  • ARCT United States
  • SPTN United States
  • Employees
  • ARCT N/A
  • SPTN N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • ARCT Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • ARCT Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • ARCT 298.3M
  • SPTN 596.4M
  • IPO Year
  • ARCT N/A
  • SPTN N/A
  • Fundamental
  • Price
  • ARCT $13.62
  • SPTN $26.54
  • Analyst Decision
  • ARCT Strong Buy
  • SPTN Hold
  • Analyst Count
  • ARCT 8
  • SPTN 1
  • Target Price
  • ARCT $52.83
  • SPTN $26.90
  • AVG Volume (30 Days)
  • ARCT 480.2K
  • SPTN 1.3M
  • Earning Date
  • ARCT 08-04-2025
  • SPTN 08-14-2025
  • Dividend Yield
  • ARCT N/A
  • SPTN 3.28%
  • EPS Growth
  • ARCT N/A
  • SPTN N/A
  • EPS
  • ARCT N/A
  • SPTN N/A
  • Revenue
  • ARCT $143,680,000.00
  • SPTN $9,652,685,000.00
  • Revenue This Year
  • ARCT N/A
  • SPTN $6.00
  • Revenue Next Year
  • ARCT $34.79
  • SPTN N/A
  • P/E Ratio
  • ARCT N/A
  • SPTN N/A
  • Revenue Growth
  • ARCT 15.38
  • SPTN 0.26
  • 52 Week Low
  • ARCT $8.04
  • SPTN $17.30
  • 52 Week High
  • ARCT $25.88
  • SPTN $26.65
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 56.99
  • SPTN 77.96
  • Support Level
  • ARCT $12.65
  • SPTN $26.37
  • Resistance Level
  • ARCT $14.58
  • SPTN $26.56
  • Average True Range (ATR)
  • ARCT 0.97
  • SPTN 0.31
  • MACD
  • ARCT 0.04
  • SPTN 0.71
  • Stochastic Oscillator
  • ARCT 58.76
  • SPTN 98.79

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: